Добірка наукової літератури з теми "Clostridium difficile toxins"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Clostridium difficile toxins".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Clostridium difficile toxins"
Giesemann, Torsten, Martina Egerer, Thomas Jank, and Klaus Aktories. "Processing of Clostridium difficile toxins." Journal of Medical Microbiology 57, no. 6 (June 1, 2008): 690–96. http://dx.doi.org/10.1099/jmm.0.47742-0.
Повний текст джерелаLyerly, D. M., H. C. Krivan, and T. D. Wilkins. "Clostridium difficile: its disease and toxins." Clinical Microbiology Reviews 1, no. 1 (January 1988): 1–18. http://dx.doi.org/10.1128/cmr.1.1.1.
Повний текст джерелаReisinger, Emil Christian, Meinolf Ebbers, and Micha Löbermann. "Clostridium difficile: Antikörpertherapie und Impfungen." DMW - Deutsche Medizinische Wochenschrift 144, no. 12 (June 2019): 842–49. http://dx.doi.org/10.1055/a-0882-7530.
Повний текст джерелаBelyi, Yu F., S. V. Fialkina, and V. I. Troitskii. "Role of toxins in Clostridium difficile pathogenicity." Experimental and Clinical Gastroenterology 160, no. 12 (December 2018): 4–10. http://dx.doi.org/10.31146/1682-8658-ecg-160-12-4-10.
Повний текст джерелаWilkins, Tracy D., and David M. Lyerly. "Clostridium difficile toxins attack Rho." Trends in Microbiology 4, no. 2 (February 1996): 49–51. http://dx.doi.org/10.1016/0966-842x(96)81508-3.
Повний текст джерелаCimolai, Nevio. "Are Clostridium difficile toxins nephrotoxic?" Medical Hypotheses 126 (May 2019): 4–8. http://dx.doi.org/10.1016/j.mehy.2019.03.002.
Повний текст джерелаKelly, C. P., C. Pothoulakis, F. Vavva, I. Castagliuolo, E. F. Bostwick, J. C. O'Keane, S. Keates, and J. T. LaMont. "Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins." Antimicrobial Agents and Chemotherapy 40, no. 2 (February 1996): 373–79. http://dx.doi.org/10.1128/aac.40.2.373.
Повний текст джерелаSalcedo, J., S. Keates, C. Pothoulakis, M. Warny, I. Castagliuolo, J. T. LaMont, and C. P. Kelly. "Intravenous immunoglobulin therapy for severe Clostridium difficile colitis." Gut 41, no. 3 (September 1, 1997): 366–70. http://dx.doi.org/10.1136/gut.41.3.366.
Повний текст джерелаMcMillin, David E., Lycurgus L. Muldrow, and Shwanda J. Laggette. "Simultaneous detection of toxin A and toxin B genetic determinants of Clostridium difficile using the multiplex polymerase chain reaction." Canadian Journal of Microbiology 38, no. 1 (January 1, 1992): 81–83. http://dx.doi.org/10.1139/m92-013.
Повний текст джерелаGovind, Revathi, Govindsamy Vediyappan, Rial D. Rolfe, and Joe A. Fralick. "Evidence that Clostridium difficile TcdC Is a Membrane-Associated Protein." Journal of Bacteriology 188, no. 10 (May 15, 2006): 3716–20. http://dx.doi.org/10.1128/jb.188.10.3716-3720.2006.
Повний текст джерелаДисертації з теми "Clostridium difficile toxins"
Karlsson, Sture. "Toxin production in Clostridium difficile /." Stockholm : Karolinska institutet, 2004. http://diss.kib.ki.se/2004/91-77349-812-2/.
Повний текст джерелаMullan, Nivette K. "Mucosal cell responses to Clostridium difficile toxins." Thesis, University of Nottingham, 2011. http://eprints.nottingham.ac.uk/13217/.
Повний текст джерелаHussack, Greg. "Single-domain Antibody Inhibitors of Clostridium difficile Toxins." Thèse, Université d'Ottawa / University of Ottawa, 2011. http://hdl.handle.net/10393/20362.
Повний текст джерелаShilling, Michael P. "Optimizing detection and control of Clostridium difficile and its toxins." Thesis, Kent State University, 2014. http://pqdtopen.proquest.com/#viewpdf?dispub=3618927.
Повний текст джерелаClostridium difficile infection (CDI) is a bacterial disease affecting the lower gastrointestinal tract of patients whose normal colonic microbiota are altered, generally by administration of antibiotic therapies. C. difficile produces toxins that cause severe diarrhea, with potentially fatal complications in the immunocompromised. CDI has spread unabated despite the best prevention efforts of clinical practitioners. This dissertation is a broad-based study of several factors of importance in prevention and control CDI. In clinical environments, transport media are used to maintain the integrity of clinical samples for later laboratory testing. A transport medium for enteric bacteria was assessed as a preservative in outpatient fecal samples submitted for CDI testing. The transport medium used preserved C. difficile toxin out to five days. The possible effect of fecal pH and trypsin content on toxin stability was investigated. Fecal pH was ruled out as a factor due to CDI selected samples tending toward neutral pH. Trypsin was found to degrade toxin in controlled experiments; however, results from clinical samples were mixed. Oils and fatty acids, including virgin coconut oil (VCO), have antimicrobial effects on a variety of human pathogens. Use of natural products like VCO may reduce or prevent CDI by killing C. difficile while preserving the protective bowel flora. Virgin coconut oil (VCO) and three of its constituent fatty acids were evaluated for their toxic effect on C. difficile and were found to have bactericidal activity, the most potent of which was lauric acid. The outer surface of C. difficile spores is thought to contain proteins that are critical for attachment of the spores to surfaces, including human hands. This strong attachment assists in transmission of infectious spores; however, the source of this strong attachment in the spore remains unknown. Transmission electron micrography shows that C. difficile lacks a true exosporium, rather, they are coated in the remains of the mother cell. Results from subsequent fluorescence microscopy and ELISA with antibodies raised against spore coat proteins confirm that this residue is not part of the spore coat and can be easily removed by chemical treatment, increasing spore binding to anti-coat antibodies.
Shilling, Michael. "OPTIMIZING DETECTION AND CONTROL OF CLOSTRIDIUM DIFFICILE AND ITS TOXINS." Kent State University / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=kent1374852321.
Повний текст джерелаTsuchiya, Ana Claudia 1987. "Avaliação de métodos e ocorrência de Clostridium difficile em carnes." [s.n.], 2012. http://repositorio.unicamp.br/jspui/handle/REPOSIP/255444.
Повний текст джерелаDissertação (mestrado) - Universidade Estadual de Campionas, Faculdade de Engenharia de Alimentos
Made available in DSpace on 2018-08-20T10:25:27Z (GMT). No. of bitstreams: 1 Tsuchiya_AnaClaudia_M.pdf: 449310 bytes, checksum: 3afe68453ac7a3b16148cef90be5c03f (MD5) Previous issue date: 2012
Resumo: Clostridium difficile é um bacilo anaeróbio responsável por doença intestinal associada ao tratamento prévio com antibióticos, manifestando desde uma diarreia leve até casos graves de colite pseudomembranosa causada principalmente pelas toxinas A (TcdA) e B (TcdB). Os casos de infecção estão relacionados à contaminação em hospitais, porém pesquisas recentes sugerem possível associação ao consumo de alimentos contaminados, pois C. difficile já foi isolado de bovinos, suínos e aves e suas carnes sugerindo os animais como reservatórios. Desta forma, os estudos são de suma importância para o entendimento da transmissão da doença causada por C. difficile. Diante de poucas pesquisas de C. difficile e da inexistência de método padronizado para seu isolamento a partir dos alimentos, o trabalho consistiu em três etapas: 1) avaliação de metodologia [utilizando dois procedimentos (tratamento com álcool e plaqueamento direto) e dois meios seletivos (ágar Clostridium difficile moxalactan norfloxacina ¿ CDMNA e ágar cicloserina cefoxitina frutose ¿ CCFA)] de detecção de C. difficile em carnes (bovina moída e peito de frango [Peitoralis profundus e superficialis]); 2) avaliação da ocorrência de C. difficile em amostras de carnes resfriadas (bovina moída, bovina peça [Semimembranosus], suína [Longuisimus dorsi] e frango [Peitoralis profundus e superficialis]), compreendendo detecção, isolamento e identificação dos isolados; 3) avaliação do perfil toxigênico dos isolados através da detecção de genes tcdA e tcdB codificadores de TcdA e TcdB e respectivamente avaliação de produção do toxinas pelos isolados. A partir da comparação de dois procedimentos, observou-se que o plaqueamento direto foi mais eficaz e recuperou uma maior quantidade de C. difficile se comparado com o tratamento com álcool e o ágar Clostridium difficile moxalactan norfloxacina (CDMNA) apresentou maior taxa de recuperação em relação ao ágar cicloserina cefoxitina frutose (CCFA). A ocorrência de C. difficile foi observada em 11,5% (17/147) das amostras analisadas, totalizando 80 isolados, destes 41,2% (33/83) apresentaram positivo para pelo menos um gene de virulência (A-B+), ou para ambos os genes (A+B+). Houve concordância de 70,5% entre os testes fenotípicos e genotípicos utilizados para detecção de toxinas. Desta forma, sugere-se que alimentos de origem animal são uma potencial fonte de transmissão de C. difficile para humanos
Abstract: Clostridium difficile is an anaerobic bacillus responsible for intestinal deseases in individuals previouslly treated with antibiocs, who can manifest from a mild diarrhea to severe cases of pseudomembranous colitis, mainly caused by toxins A (TcdA) and B (TcdB). The infections are related to contamination in hospitals, but recent researches sugests a possible association with the consumiption of contaminated foods as C. difficile has been isolated from bovines, suines and poultries and their meat, sugesting animals as reservatories. Thus, studies are extremelly important to elucidate the transmition of the desease caused by C. difficile. Faced with few researches about this bacteria and the lack of a standard method for its isolation from food, this work is divided in three steps: 1) Evaluation of the methodology for C. difficile detection in meet (commercial bovine mince and chicken breast ¿ [Peitoralis superficialis and Peitoralis profundus] [using two procedures (treatment with alcohol and direct plating) and two selective mediums (agar Clostridium difficile moxalactan norfloxacin ¿ CDMNA and cycloserine cefoxitin fructose agar¿ CCFA)]; 2) Assessing of the occurrence of C. difficile in samples of chilled meat (bovine: commercial mince and the whole Semimembranosus; suine: whole Longuisimus dorsi; chicken: Peitoralis profundus and Peitoralis superficialis) by detection, isolation and identification of the isolated; 3) Evaluation of the toxicogenic profile of the isolated by the detection of the genes tcdA and tcdB, which are encoding of TcdA and TcdB respectivelly, and the capacity of toxine production by the isolated bacterias. From the comparison of the two proceeding above it was observed that the direct plating was more efficient and recovered a larger aumont of C. difficile than the treatment with alcohol. Furthermore, the CDMNA agar presented a higher recovery rate compared to CCFA agar. It was observed the occurrence of C. difficile in 11,5% (17/147) of the analyzed samples, comprising 80 isolates, of which 41,2% (33/83) showed a positive response for at least one virulence gene (A-B+), or for both genes (A+B-). In addition, there was a 70,5% concordance between the phenotypic and genotypic tests used to detect toxins. In this way, it is suggested that foods of animal origin are a potential source of transmission of C. difficile for humans
Mestrado
Tecnologia de Alimentos
Mestre em Tecnologia de Alimentos
Davies, Abigail. "Structure and biochemical analysis of toxins from the superbug Clostridium difficile." Thesis, University of Bath, 2014. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.619282.
Повний текст джерелаMartinez, Ramon D. "Purification and characterization of Clostridium sordellii toxins HT and LT and comparison to toxins A and B of Clostridium difficile." Diss., Virginia Polytechnic Institute and State University, 1989. http://hdl.handle.net/10919/54238.
Повний текст джерелаPh. D.
Vohra, Prerna. "Clostridium difficile : expression of virulence factors, resistance to disinfectants and interactions with human cells." Thesis, University of Edinburgh, 2012. http://hdl.handle.net/1842/6490.
Повний текст джерелаJefferson, Kimberly Kay. "Clostridium difficile toxins A and B: exploring the possible mechanism of action." Thesis, Virginia Tech, 1995. http://hdl.handle.net/10919/45056.
Повний текст джерелаClostridium difficile is a common cause of antibiotic-associated diarrhea and
occasionally causes the life-threatening disease pseudomembranous colitis. The
pathogenicity of the organism has been attributed to the production of two large
exotoxins, toxin A (308,000 daltons) and toxin B (269,000 daltons). Toxin A is a
powerful enterotoxin and is generally thought to play the more important role in the
pathology of the disease. Toxin B may exert its effect after the initial tissue damage by
toxin A. Both toxins cause rounding of mammalian culture cells by disrupting the
cytoskeletal system. The similar biological activities and high percentage of sequence
homology between the two toxins suggest that they have a similar mechanism of action.
I found that purified preparations of both toxins cleave skeletal muscle actin at a single
site, producing a 38,000 dalton actin fragment, and that the toxins are capable of
autodigestion. The proteolytic activity may be involved in the mechanism of action of
the toxins. I also analyzed an aberrant strain of C. difficile which reportedly lacked the
gene for toxin B. Such a strain would be very useful for the study of the mechanism of
toxin A. I concluded however, that the strain contained the genes for both toxin A and
toxin B. The toxin genes and resulting proteins appear, however, to be slightly different
from those of other strains.
Master of Science
Книги з теми "Clostridium difficile toxins"
Ketley, Julian Mark. Studies on toxins A and B of Clostridium difficile. Birmingham: University of Birmingham, 1986.
Знайти повний текст джерелаPapatheodorou, Panagiotis. Clostridium difficile binary toxin CDT induces clustering of the lipolysis-stimulated lipoprotein receptor into lipid rafts. Freiburg: Universität, 2013.
Знайти повний текст джерелаMitchell, Timothy John. Studies on the mode of action of Clostridium difficile toxin A. Birmingham: University of Birmingham, 1986.
Знайти повний текст джерелаUrtz, Bruce E. Purification and characterization Clostridium difficile toxin A. 1987.
Знайти повний текст джерелаMasnyk, Michael. The interactions of Clostridium Difficile Toxin B with mammalian cells. 1988.
Знайти повний текст джерелаKatirji, Bashar. Case 24. Edited by Bashar Katirji. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190603434.003.0028.
Повний текст джерелаЧастини книг з теми "Clostridium difficile toxins"
Moncrief, J. S., and T. D. Wilkins. "Genetics of Clostridium difficile Toxins." In Current Topics in Microbiology and Immunology, 35–54. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-662-06272-2_2.
Повний текст джерелаWarny, Michel, and Ciarán P. Kelly. "Pathogenicity of Clostridium difficile Toxins." In Microbial Pathogenesis and the Intestinal Epithelial Cell, 503–24. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555817848.ch27.
Повний текст джерелаDelmée, Michel, and Michel Warny. "Antibody response to Clostridium difficile toxins." In Ökosystem Darm Special, 83–91. Paris: Springer Paris, 1996. http://dx.doi.org/10.1007/978-2-8178-0903-8_9.
Повний текст джерелаDelmée, Michel, and Michel Warny. "Antibody response to Clostridium difficile toxins." In Ökosystem Darm Special, 83–91. Paris: Springer Paris, 1996. http://dx.doi.org/10.1007/978-2-8178-0924-3_9.
Повний текст джерелаvon Eichel-Streiber, Christoph. "Molecular Biology of the Clostridium difficile Toxins." In Brock/Springer Series in Contemporary Bioscience, 264–89. New York, NY: Springer New York, 1993. http://dx.doi.org/10.1007/978-1-4615-7087-5_19.
Повний текст джерелаThelestam, M., and E. Chaves-Olarte. "Cytotoxic Effects of the Clostridium difficile Toxins." In Current Topics in Microbiology and Immunology, 85–96. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-662-06272-2_4.
Повний текст джерелаBorriello, S. P. "Structure and Function of Clostridium difficile Toxins." In Molecular Pathogenesis of Gastrointestinal Infections, 161–67. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-5982-1_21.
Повний текст джерелаLópez-Ureña, Diana, Carlos Quesada-Gómez, César Rodríguez, and Esteban Chaves-Olarte. "Role of Clostridium difficile Toxins in Antibiotic-Associated Diarrhea and Pseudomembranous Colitis." In Microbial Toxins, 1–18. Dordrecht: Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-007-6725-6_17-1.
Повний текст джерелаBarbut, Frédéric, and Jean-Claude Petit. "Laboratory methods for detecting the toxins of Clostridium difficile." In Ökosystem Darm Special, 93–104. Paris: Springer Paris, 1996. http://dx.doi.org/10.1007/978-2-8178-0903-8_10.
Повний текст джерелаBarbut, Frédéric, and Jean-Claude Petit. "Laboratory methods for detecting the toxins of Clostridium difficile." In Ökosystem Darm Special, 93–104. Paris: Springer Paris, 1996. http://dx.doi.org/10.1007/978-2-8178-0924-3_10.
Повний текст джерелаТези доповідей конференцій з теми "Clostridium difficile toxins"
Monaghan, TM, O. Negm, B. MacKenzie, M. Hamed, CC Shone, DP Humphreys, KR Acharya, and MH Wilcox. "PWE-017 High prevalence of subclass-specific binding and neutralising antibodies against clostridium difficile toxins in adult cystic fibrosis sera: possible mode of protection against symptomatic clostridium difficile infection." In British Society of Gastroenterology, Annual General Meeting, 19–22 June 2017, Abstracts. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2017. http://dx.doi.org/10.1136/gutjnl-2017-314472.262.
Повний текст джерелаMatos, Eduarda Syhara Rocha, Costa, D.V.S., Martins, C.S., Oliveira, L.C., Silva, A.M.H.P., Martins, D.S., Pimentel, P.V.S., and Brito, G.A.C. "Alterações neuroimunes induzidas por toxinas do Clostridium difficile." In II Encontro do Programa de Pós-Graduação em Ciências Farmacêuticas da Universidade Federal do Ceará e I Simpósio Norte-Nordeste de Ciências Farmacêuticas. Fortaleza - CE, Brazil: Galoa, 2017. http://dx.doi.org/10.17648/ppgcf-2017-64895.
Повний текст джерелаProhaska, C., and M. F. Ragland. "A Toxic Combination: Clostridium Difficile Infection Leading to Miscarriage." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6573.
Повний текст джерелаЗвіти організацій з теми "Clostridium difficile toxins"
Muldrow, Lycurgus L., and Joe Johnson. Genetic Engineering of Clostridium Difficile Toxin A Vaccine. Fort Belvoir, VA: Defense Technical Information Center, September 1991. http://dx.doi.org/10.21236/ada242265.
Повний текст джерелаMuldrow, Lycurgus L., and Joe Johnson. Genetic Engineering of Clostridium Difficile Toxin a Vaccine. Fort Belvoir, VA: Defense Technical Information Center, August 1990. http://dx.doi.org/10.21236/ada230411.
Повний текст джерела